Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於最新
$21,294 交易量
2026-12-31
2026 年 12 月 31 日
4%
2027年6月30日
11%
$21,294 交易量
2026 年 12 月 31 日
$14,632 交易量
4%
2027年6月30日
$6,662 交易量
11%
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
市場開放時間： Sep 18, 2026, 8:27 PM ET
交易量
$21,294結束日期
2027-07-01市場開放時間
Sep 18, 2026, 8:27 PM ETThis market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
交易量
$21,294結束日期
2027-07-01市場開放時間
Sep 18, 2026, 8:27 PM ETAnthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions